RMG Wealth Management’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

RMG Wealth Management’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,978	Closed	-$769K	–	665
2025 Q4	$769K	Buy	+2,978	New	+$769K	0.1%	22

RMG Wealth Management's LDRS Position: Q1 2026 in Review

RMG Wealth Management sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q1 2026, closing a stake of 2,978 shares — an estimated $769K sold.

RMG Wealth Management first reported a position in LDRS in Q4 2025 and held it in 1 quarter. The position peaked at $769K in Q4 2025. 0 funds tracked by Wall St. Rank hold LDRS as of Q1 2026.

RMG Wealth Management reported no remaining Innovator IBD ETF Leaders ETF position as of Q1 2026 after selling out during the quarter.
RMG Wealth Management sold 2,978 Innovator IBD ETF Leaders ETF shares in Q1 2026, an estimated $769K.
RMG Wealth Management first reported a position in Innovator IBD ETF Leaders ETF in Q4 2025 and held it in 1 quarter.
RMG Wealth Management's Innovator IBD ETF Leaders ETF position peaked at $769K in Q4 2025.
0 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q1 2026.

Based on RMG Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.